Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Previous studies have shown that patients with Takotsubo syndrome (TS) have supranormal nitric oxide signaling, and post-mortem studies of TS heart samples revealed nitrosative stress. Therefore, we first showed in a female rat model that isoproterenol induces TS-like echocardiographic changes, evidence of nitrosative stress, and consequent activation of the energy-depleting enzyme poly(ADP-ribose) polymerase-1. We subsequently showed that pre-treatment with an inhibitor of poly(ADP-ribose) polymerase-1 ameliorated contractile abnormalities. These findings thus add to previous reports of aberrant β-adrenoceptor signaling (coupled with nitric oxide synthase activation) to elucidate mechanisms of impaired cardiac function in TS and point to potential methods of treatment.

More information Original publication

DOI

10.1016/j.jacbts.2017.10.002

Type

Journal article

Publication Date

2018-04-01T00:00:00+00:00

Volume

3

Pages

213 - 226

Total pages

13

Keywords

3AB, 3-aminobenzamide, ANOVA, analysis of variance, ISO, isoproterenol, LV, left ventricular, NFκB, nuclear factor kappa B, NO, nitric oxide, NOS, nitric oxide synthase, NT, nitrotyrosine, O2–, superoxide, ONOO–, peroxynitrite, PAR, poly(ADP-ribose), PARP, poly(ADP-ribose) polymerase, TS, Takotsubo syndrome, TXNIP, thioredoxin-interacting protein, Takotsubo cardiomyopathy, myocardial inflammation, oxidative stress, poly(ADP-ribose) polymerase-1